Journal article · 2022 · Open access

A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development

Nicholas Giangreco, Nicholas P. Tatonetti

Med, 3(8), 579–595.e7 · Published 24 June 2022 · DOI 10.1016/j.medj.2022.06.001

Open PDFView at the publisherCite this paper

In brief

“A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development” is a 2022 journal article by Nicholas Giangreco and Nicholas P. Tatonetti, published in Med. OpenAlex counts 19 citations as of 19 November 2026, which puts it in the top 5% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Med.

Citations
19
Most cited in
2026 (8)
Field-weighted impact
1.42
References
57
Authors
2

Abstract

BACKGROUND: Adverse drug effects (ADEs) in children are common and may result in disability and death, necessitating post-marketing monitoring of their use. Evaluating drug safety is especially challenging in children due to the processes of growth and maturation, which can alter how children respond to treatment. Current drug safety-signal-detection methods do not account for these dynamics. METHODS: We recently developed a method called disproportionality generalized additive models (dGAMs) to better identify safety signals for drugs across child-development stages. FINDINGS: We used dGAMs on a database of 264,453 pediatric adverse-event reports and found 19,438 ADEs signals associated with development and validated these signals against a small reference set of pediatric ADEs. Using our approach, we can hypothesize on the ontogenic dynamics of ADE signals, such as that montelukast-induced psychiatric disorders appear most significant in the second year of life. Additionally, we integrated pediatric enzyme expression data and found that pharmacogenes with dynamic childhood expression, such as CYP2C18 and CYP27B1, are associated with pediatric ADEs. CONCLUSIONS: We curated KidSIDES, a database of pediatric drug safety signals, for the research community and developed the Pediatric Drug Safety portal (PDSportal) to facilitate evaluation of drug safety signals across childhood growth and development. FUNDING: This study was supported by grants from the National Institutes of Health (NIH).

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Giangreco, N., & Tatonetti, N. P. (2022). A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development. Med, 3(8), 579–595.e7. https://doi.org/10.1016/j.medj.2022.06.001

MLA 9

Giangreco, Nicholas, and Nicholas P. Tatonetti. “A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development.” Med, vol. 3, no. 8, 2022, pp. 579–595.e7. https://doi.org/10.1016/j.medj.2022.06.001.

Chicago

Giangreco, Nicholas and Nicholas P. Tatonetti. 2022. “A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development.” Med 3 (8): 579–595.e7. https://doi.org/10.1016/j.medj.2022.06.001.

Harvard

Giangreco, N. and Tatonetti, N. P. (2022) ‘A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development’, Med, 3(8), pp. 579–595.e7. doi:10.1016/j.medj.2022.06.001.

IEEE

N. Giangreco and N. P. Tatonetti, “A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development,” Med, vol. 3, no. 8, pp. 579–595.e7, 2022, doi: 10.1016/j.medj.2022.06.001.

BibTeX

@article{giangreco2022database,
  title     = {{A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development}},
  author    = {Giangreco, Nicholas and Tatonetti, Nicholas P.},
  journal   = {Med},
  year      = {2022},
  volume    = {3},
  number    = {8},
  pages     = {579--595.e7},
  doi       = {10.1016/j.medj.2022.06.001},
  url       = {https://doi.org/10.1016/j.medj.2022.06.001}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202433
202577
202688

Its field-weighted citation impact is 1.42: it has been cited 1.42 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions

  • drug safety signals
  • child growth and development
  • drug metabolism genes
  • CYP2C18
  • CYP27B1
  • montelukast
  • mental illness
  • post-marketing surveillance

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Giangreco, N., & Tatonetti, N. P. (2022). A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development. Med, 3(8), 579–595.e7. https://doi.org/10.1016/j.medj.2022.06.001

How many times has this paper been cited?

19 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Med: sign in and open the PDF from this page.

Who wrote this paper?

Nicholas Giangreco, Nicholas P. Tatonetti.

What is the DOI of this paper?

10.1016/j.medj.2022.06.001, permanently at https://doi.org/10.1016/j.medj.2022.06.001. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.